title: Sweet syndrome: adverse drug reaction or novel manifestation of HIV-associated immune reconstitution inflammatory syndrome?
authors.forename: Lewis John
authors.initials: LJ
authors.lastname: Haddow
authors.forename: Rannakoe
authors.initials: R
authors.lastname: Lehloenya
authors.forename: Anisa
authors.initials: A
authors.lastname: Mosam
authors.forename: Shumani
authors.initials: S
authors.lastname: Malaka
authors.forename: Mahomed-Yunus Suleman
authors.initials: MY
authors.lastname: Moosa
mesh_terms: D000328:Adult; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D001707:Biopsy, Needle; D003937:Diagnosis, Differential; D005260:Female; D005500:Follow-Up Studies; D015658:HIV Infections / Q000175:diagnosis / Q000188:drug therapy*; D006679:HIV Seropositivity; D006801:Humans; D054019:Immune Reconstitution Inflammatory Syndrome / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology*; D007150:Immunohistochemistry; D008875:Middle Aged; D012720:Severity of Illness Index; D016463:Sweet Syndrome / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology*